Jun 16, 2020
Intermolecular Announces Breakthrough Four-Element ALD Chalcogenide-based OTS for 3D Memory Arrays
Jun 08, 2020
Prime Therapeutics and EMD Serono ink value-based agreement on MAVENCLAD® (cladribine) tablets
May 28, 2020
Merck KGaA, Darmstadt, Germany, and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living with MS
May 27, 2020
Rebif® U.S. Label Now Includes Pregnancy Outcomes and Lactation Information to Help Inform Treatment Decisions for Women with MS
May 27, 2020
MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19
May 23, 2020
New Late-Breaking Data at EAN Indicate Evobrutinib is the First BTK Inhibitor to Report Efficacy and Safety in MS Over 108 Weeks
May 19, 2020
NIIMBL Announces $10M in New Project Funding Towards Advances in Biopharmaceutical Manufacturing Innovation
May 13, 2020
Breakthrough Innovation in Cancer Care From EMD Serono Pipeline to Be Presented at ASCO 2020
Apr 30, 2020
Data From EMD Serono at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
Mar 25, 2020
TEPMETKO® (Tepotinib) Approved in Japan for Advanced NSCLC with METex14 Skipping Alterations
Mar 19, 2020
Multiple Sclerosis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast (2019 to 2027)
Mar 13, 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Feb 06, 2020
EMD Serono Receives Positive Recommendation for MAVENCLAD® (cladribine tablets) for the treatment of Relapsing-Remitting Multiple Sclerosis from the Institut national d'excellence en santé et en services sociaux (INESSS)
Jan 13, 2020
Boston IVF Announces New CEO
Dec 18, 2019
Merck Foundation CEO, Rasha Kelej Named Among Top 100 Most Influential Africans
Dec 10, 2019
EMD Serono and the pan-Canadian Pharmaceutical Alliance Complete Negotiations for MAVENCLAD® (cladribine tablets) for the treatment of Relapsing-Remitting Multiple Sclerosis
Dec 04, 2019
Ping An Good Doctor and Merck KGaA, Darmstadt, Germany Form Strategic Collaboration to Advance Intelligent Healthcare in China
Dec 02, 2019
Oncopeptides Appoints Joseph Horvat as President North America
Nov 20, 2019
Merck KGaA, Darmstadt, Germany, Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations
Nov 05, 2019
Medisafe Announces Strong Results from Digital Medication Management Programs